SANGUEDOLCE, Rosario
 Distribuzione geografica
Continente #
NA - Nord America 2.222
EU - Europa 1.249
AS - Asia 277
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 3.759
Nazione #
US - Stati Uniti d'America 2.222
IT - Italia 288
UA - Ucraina 268
FI - Finlandia 259
CN - Cina 226
DE - Germania 97
IE - Irlanda 97
SE - Svezia 65
GB - Regno Unito 59
RO - Romania 33
RU - Federazione Russa 33
KR - Corea 19
FR - Francia 15
BE - Belgio 14
IN - India 14
EU - Europa 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
IR - Iran 4
NL - Olanda 4
SG - Singapore 4
TN - Tunisia 4
HK - Hong Kong 3
LB - Libano 3
TR - Turchia 3
AT - Austria 2
ES - Italia 2
GR - Grecia 2
PL - Polonia 2
AU - Australia 1
BY - Bielorussia 1
JP - Giappone 1
MA - Marocco 1
Totale 3.759
Città #
Ashburn 244
Ann Arbor 243
Chandler 241
Fairfield 157
Jacksonville 147
Woodbridge 140
Wilmington 121
Des Moines 117
Dublin 88
Houston 79
Medford 68
Seattle 60
Nanjing 54
Cambridge 50
Palermo 47
Princeton 43
New York 42
Tulsa 35
Boardman 32
Altamura 30
Dearborn 30
Lawrence 21
Beijing 20
Seongnam 19
Nanchang 18
Hebei 17
Shenyang 17
Auburn Hills 16
Jinan 16
San Diego 15
Brussels 14
Ludwigshafen am Rhein 14
Los Angeles 13
Milan 13
Changsha 12
Helsinki 10
Jiaxing 10
Tianjin 10
Washington 10
Saint Petersburg 9
Venice 9
Kumar 8
Ningbo 8
Partinico 8
Falls Church 7
Nuremberg 7
San Mateo 7
Verona 7
Zhengzhou 7
Hefei 5
Kunming 5
Lanzhou 5
Bremen 4
Hangzhou 4
Menlo Park 4
San Paolo di Civitate 4
Singapore 4
Taizhou 4
Tehran 4
Düsseldorf 3
Hanover 3
Henderson 3
Izmir 3
Prague 3
Taiyuan 3
Terrasini 3
Andover 2
Cattolica 2
Fuzhou 2
Guangzhou 2
Hong Kong 2
Indiana 2
Kiev 2
Lentini 2
London 2
Mehlingen 2
Partanna 2
Regensburg 2
Rome 2
Aarau 1
Alcamo 1
Amsterdam 1
Baotou 1
Barcelona 1
Buffalo 1
Catania 1
Cedar Knolls 1
Central District 1
Como 1
Den Haag 1
Denver 1
Favara 1
Francofonte 1
Frankfurt Am Main 1
Fremont 1
Groningen 1
Haikou 1
Kagoshima 1
Leawood 1
Ludwigshafen 1
Totale 2.521
Nome #
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 197
Difference in Ki67 and thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients. 172
Clinical relevance of thymidylate syntetase expression in the signet ring cell histotype component of colorectal carcinoma 151
Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma 150
Different expression of thymidylate synthase in primary tumour and metastatic nodes in breast cancer patients. 140
Thymidylate Synthase polymorphism and microsatellite instability: association in colorectal cancer 124
Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer 123
Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma. 117
Difference in Ki67 and Thymidylate synthase expression in primary tumour compared with metastatic nodes in breast cancer patients 113
Analysis of the thymidylate syntethase gene structure in colorectal cancer patients, and its possible relation with the 5-fluoruracil drug response 111
Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and lts Possible Relation with the S-Fluorouracil Drug Response 106
The significance of the Thymidylate Synthase expression in the Signet Ring Cell component of colorectal carcinoma 105
La Real Casa dei Matti di Palermo: storia di un'innovazione terapeutica tra architettura e letteratura 105
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 104
Low cell proliferation marker and low thymidylate synthase levels in the highly aggressive signet ring cell variant histotype of colorectal carcinoma 96
Analysis of coding and non-coding regions of thymidylate syntetase gene in colorectal cancer patients and its possible relationship with 5-fluorouracil drug response 96
Difference in ki67 and thymidylate synthase expression in primary tumour compared with metastastic nodes in breast cancer patients. european society for the study of purine and pyrimidine metabolism in man 95
LOW CELL PROLIFERATION AND LOW THYMIDYLATE SYNTHASE LEVELS IN THE HIGHLY AGGRESSIVE SIGNET RING CELL VARIANT HISTOTYPE OF COLORECTAL CARCINOMA 94
DIFFERENT EXPRESSION OF E-CADHERINE, BETA-CATENIN, AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL COLORECTAL CARCINOMA. 89
Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer 88
Relationship between Thymidylate synthase and p53 and response versus taxane adjuvant chemotherapy for breast carcinoma 88
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 85
Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer 81
Myeloid zinc finger 1 regulates thymidylate synthase expression in patients with metastatic colorectal cancer showing the same promoter gene polymorphism 79
Could a variant structural form of thymidylate synthase gene of metastatic colorectal cancer patients be related with the poor response to 5 Fu treatment? 77
Different expression of e-cadherin, beta-catenin and fibronectin in signet ring cell, and intestinal colorectal carcinoma 69
Difference in ki67 and thymidylate synthase expression in primary tumour compared with metastastic nodes in breast cancer patients 68
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophosphamide, methotrexate, 5-fluorouracil chemotherapy(CMF) versus docetaxel (TXT) in locally advanced carcinoma of the breast. 67
DIFFERENT EXPRESSION OF E-CADERINE, BETA CATENIN AND FIBRONECTIN IN SIGNET RING CELL AND INTESTINAL CARCINOMA. 67
Decreased expression of thymidylate synthase and low proliferation index by Ki67 in "signet ring cell component of colorectal carcinoma" 67
Relationdhip between the thymidylate synthase, P53 levels and the treatment by CMF drug combination versus taxanes in the locally advanced carcinoma of breast 66
Relationship between the thymidiylate synthase, P53 levels and the treatment by CMF drug combination versus taxanes in the locally advanced carcinoma of the breast 64
Possible role of differential metalloproteinase 1 expression in signet ring cell and intestinal colorectal carcinoma histotypes 62
Difference in ki67 and Thimidylate Synthase expressin in primary tumour compared with metastatic nodes in breast cancer patients 61
DIFFERENCE IN KI67 AND THYMIDYLATE SYNTHASE, P53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST 60
Does P-glycoprotein-170 expression predict for chemoresistance in transitional cell carcinoma of the bladder? 57
RELATIONSHIP BETWEEN THE THYMIDYLATE SYNTHASE, p53 LEVELS AND THE TREATMENT BY CMF DRUG COMBINATION VERSUS TAXANES IN THE LOCALLY ADVANCED CARCINAMO OF THE BREAST 55
Decreased expression of thymidylate synthase and low proliferation index assessed by ki67 in " signet ring cell component" of colorectal carcinomas 55
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. 53
Relationship between the thymidylate synthase, p53 levels and the treatment by CMF drug combination versus taxanes in the locally advanced carcinoma of breast. 49
RELATIONSHIP BETWEEN THYMIDYLATE SYNTHASE EXPRESSION AND p53 LEVELS WITH THE TREATMENT BY CYCLOPHOSPHAMIDE, 5-FLUOROURACIL CHEMOTHERAPY (CMF) VERSUS DOCETAXEL IN THE LOCALLY ADVANCED CARCINOMA OF THE BREAST. 45
Relationship between thymidylate synthase expression and p53 levels with the treatment of cyclophsphamide, methotrexate, 5-fluorouracil chemotherapy ( CMF)versus docetaxel ( TXT) in locally advanced carcinoma of the breast 42
Expression of a specific Thymidylate synthase polimorfic allele in metastatic colorectal patients is regulated by Myeloid Zinc Finger 1. 41
Low cell proliferation marker and low thymidylate synthase levels in the highly aggressive signet ring cell variant histotype of colorectal carcinoma 22
null 8
Totale 3.864
Categoria #
all - tutte 11.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201994 0 0 0 0 0 0 0 0 0 14 37 43
2019/2020732 110 26 47 23 68 87 82 24 71 94 59 41
2020/2021553 12 43 9 144 72 10 41 22 67 26 52 55
2021/2022450 17 105 4 15 22 16 15 20 71 44 28 93
2022/2023691 90 103 10 76 74 115 98 36 64 2 20 3
2023/2024368 8 54 15 17 34 88 96 38 0 18 0 0
Totale 3.864